Welcome to LookChem.com Sign In|Join Free


  • or


Post Buying Request

67287-53-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

67287-53-0 Usage

General Description

6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine is a chemical compound that belongs to the class of benzazepines. It contains a chloro group and two methoxy groups, as well as a 4-methoxyphenyl substituent. 6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine has potential pharmacological activity and may be used in the development of drugs for various medical purposes. Its specific properties and uses would depend on further research and testing.

Check Digit Verification of cas no

The CAS Registry Mumber 67287-53-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,2,8 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 67287-53:
160 % 10 = 0
So 67287-53-0 is a valid CAS Registry Number.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017


1.1 GHS Product identifier

Product name 9-chloro-7,8-dimethoxy-5-(4-methoxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine

1.2 Other means of identification

Product number -
Other names 6-chloro-7,8-dimethoxy-1-(4-methoxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:67287-53-0 SDS

67287-53-0Relevant articles and documents

A hand natural Philippines Duopan splitting method


Paragraph 0049; 0050; 0051, (2017/08/25)

The invention discloses resolution of a D1 dopamine receptor agonist drug and in particular discloses a resolution method of fenoldopam. The resolution method of the D1 dopamine receptor agonist drug comprises the steps of protecting a phenolic hydroxyl group and an amino group in the structure of fenoldopam, then carrying out chemical resolution with a chiral acidic resolution agent to obtain a pure optical isomer, and finally removing a protecting group and salifying to obtain optically pure methanesulfonic acid fenoldopam.

Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: Halogen and methyl analogues of fenoldopam

Weinstock,Ladd,Wilson,Brush,Yim,Gallagher Jr.,McCarthy,Silvestri,Sarau,Flaim

, p. 2315 - 2325 (2007/10/02)


Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines


, (2008/06/13)

A group of 6,9-disubstituted-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines have dopaminergic activity. Examples of leading species of the invention are 6,9-dichloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and 6,9-dichloro-7,8-dihydroxy-1-(p-hydroxy-phenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine in the form of an acid addition salt.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)


What can I do for you?
Get Best Price

Get Best Price for 67287-53-0